Nefedov V B, Popova L A
Klin Med (Mosk). 1999;77(12):30-3.
Lung capacity (LC), functional lung capacity (FLC), FEV1, FEV1/LC%, CO25, CO50, CO75 were measured in 56 patients with bronchial asthma in attach-free period before and after inhalation of one-dose berotec and one-dose atrovent. Bronchospasm was registered in 66% of the patients. It was the only cause of bronchial obstruction in 12% of the patients and one of the causes in 54% of them. Contribution of the bronchospasm to development of bronchial obstruction was, as a rule, dominating. This contribution reached 81-100% in 60% of the patients.
在56例支气管哮喘患者吸入一剂必可酮和一剂爱全乐前后的缓解期,测量其肺容量(LC)、功能性肺容量(FLC)、第一秒用力呼气容积(FEV1)、FEV1/LC%、25%一氧化碳弥散量(CO25)、50%一氧化碳弥散量(CO50)、75%一氧化碳弥散量(CO75)。66%的患者出现支气管痉挛。它是12%患者支气管阻塞的唯一原因,是54%患者支气管阻塞的原因之一。通常,支气管痉挛对支气管阻塞发展的影响占主导地位。60%的患者中,这种影响达到81%-100%。